Chunrui Li, MD, PhD¹, Di Wang, MD, PhD^2*, Yongping Song^3*, Jianyong Li⁴, He Huang^5,6, Bing Chen^7*, Jing Liu^8*, Kai Hu^9*, Hanyun Ren, MD¹⁰, Xi Zhang^11*, Zhenyu Li, MD^12*, Dehui Zou^13*, Qingsong Yin^14*, Lijuan Chen, MD, PhD^15*, Yongxian HU, MD^16*, Yong Xu, PhD^17*, Qian Cheng^18*, Yuelu Guo^19*, Yujun Dong, MD^10*, Li Gao^20,21*, Aining Xu^22*, Songbai Cai^23*, Wen Wang^24*, Ming Wu^23*, Jue Wang, MD, PhD^25*, Liting Chen^26*, Jianfeng Zhou^1* and Lugui Qiu¹³

¹Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
²Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
³Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China
⁴Department of Hematology, Pukou CLL Center, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China
⁵Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
⁶Institute of Hematology, Zhejiang University, Hangzhou, China
⁷Department of Hematology, Nanjing University Medical School , the Affiliated Nanjing Drum Tower Hospital, NanJing, China
⁸Department of Hematology, The Third Xiangya Hospital of Central South University, Hunan, China
⁹Department of Hematology, Beijing Boren Hospital, Beijing, China
¹⁰Department of Hematology, Peking University First Hospital, Beijing, China
¹¹Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing, China
¹²Department of Hematology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
¹³State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
¹⁴the Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Zhengzhou, China
¹⁵Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
¹⁶Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, AL, China
¹⁷Department of Hematology, Nanjing University Medical School, the Affiliated Nanjing Drum Tower Hospital, Nanjing, China
¹⁸Department of Hematology, The Third Xiangya Hospital of Central South University, Changsha, China
¹⁹Beijing Boren Hospital, Beijing, AK, China
²⁰Department of Hematology, Xinqiao Hospital, Army medical University, Chongqing, China
²¹The Second Affiliated Hospital of Army Medical University, Chongqing, China
²²Nanjing IASO Biotherapeutics Ltd, Nanjing, Jiangsu, Nanjing, China
²³Nanjing IASO Biotherapeutics Ltd, Shanghai, China
²⁴Nanjing IASO Biotherapeutics Ltd, Nanjing, CHN
²⁵Department of Hematology,Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
²⁶Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science, Wuhan, China

Noopur S. Raje, MD¹, Nina Shah, MD², Sundar Jagannath³, Jonathan L. Kaufman, MD⁴, David S. Siegel, MD, PhD⁵, Nikhil C. Munshi, MD, PhD⁶, Jacalyn Rosenblatt, MD⁷, Yi Lin⁸, Andrzej Jakubowiak⁹, Alison Timm, MA^10*, Ashish Yeri, PhD^10*, Nathan Martin, PhD^11*, Timothy B. Campbell, MD, PhD^11*, Olivia Finney, PhD^10*, Anna Truppel-Hartmann, MD^10*, Fabio Petrocca, MD^10*, Jesús G. Berdeja¹² and Melissa Alsina, MD¹³

¹Division of Hematology and Oncology, Mass General Hospital Cancer Center, Boston, MA
²University of California San Francisco, San Francisco, CA
³Department of Medicine, Hematology and Medical Oncology, Mount Sinai Medical Center, New York, NY
⁴Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
⁵Hackensack Univ. Med. Ctr., Hackensack, NJ
⁶Dana-Farber Cancer Institute, Harvard Medical School, Boston
⁷Beth Israel Deaconess Medical Center, Boston, MA
⁸Mayo Clinic, Rochester, MN
⁹University of Chicago, Chicago, IL
¹⁰bluebird bio, Cambridge, MA
¹¹Bristol Myers Squibb, Princeton, NJ
¹²Sarah Cannon Research Institute, Nashville, TN
¹³Department of Blood & Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Ctr. Hematologic Malignancies Program, Tampa, FL

Thomas Martin¹, Saad Z. Usmani, MD MBA FACP², Jesús G. Berdeja³, Andrzej Jakubowiak⁴, Mounzer Agha⁵, Adam D Cohen⁶, Parameswaran Hari⁷, David Avigan, MD⁸, Abhinav Deol⁹, Myo Htut¹⁰, Alexander Lesokhin, MD¹¹, Nikhil C. Munshi, MD, PhD¹², Elizabeth O’Donnell, MD^13*, A. Keith Stewart, MBChB¹⁴, Jordan M. Schecter¹⁵, Jenna D. Goldberg^15*, Carolyn C. Jackson^15*, Tzu-Min Yeh^15*, Arnob Banerjee^16*, Alicia Allred^16*, Enrique Zudaire^16*, William Deraedt^17*, Deepu Madduri^15,18*, Yunsi Olyslager^17*, Changwei Zhou^19*, Lida Pacaud^19*, Yi Lin²⁰ and Sundar Jagannath, MD^18*

¹UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
²Levine Cancer Institute, New York, NY
³Sarah Cannon Research Institute, Nashville, TN
⁴University of Chicago, Chicago, IL
⁵UPMC Hillman Cancer Center, Pittsburgh, PA
⁶Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁷Medical College of Wisconsin, Milwaukee, WI
⁸Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
⁹Karmanos Cancer Institute, Wayne State University, Detroit, MI
¹⁰Comprehensive Cancer Center, City of Hope National Medical Center, Duarte, CA
¹¹Memorial Sloan Kettering Cancer Center, New York, NY
¹²Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
¹³Harvard Medical School, Boston, MA
¹⁴University of Toronto, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
¹⁵Janssen R&D, Raritan, NJ
¹⁶Janssen R&D, Spring House, PA
¹⁷Janssen R&D, Beerse, Belgium
¹⁸Mount Sinai Medical Center, New York, NY
¹⁹Legend Biotech USA, Piscataway, NJ
²⁰Mayo Clinic, Rochester, MN

Maria-Victoria Mateos¹, Katja Weisel^2*, Thomas Martin, MD³, Jesús G. Berdeja⁴, Andrzej Jakubowiak⁵, A. Keith Stewart, MBChB⁶, Sundar Jagannath, MD^7*, Yi Lin⁸, Joris Diels^9*, Francesca Ghilotti^10*, Nolen J Perualila^9*, Jedelyn Cabrieto^9*, Benjamin Haefliger^11*, Nichola Erler-Yates^12*, Clare Hague^13*, Carolyn C. Jackson^14*, Vadim Strulev^9*, Tonia Nesheiwat^15*, Lida Pacaud^15*, Philippe Moreau, MD, PhD^16* and Hermann Einsele¹⁷

¹University Hospital of Salamanca/IBSAL, CIC, Salamanca, Spain
²University Medical Center Hamburg-Eppendorf, Hamburg, Germany
³UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
⁴Sarah Cannon Research Institute, Nashville, TN
⁵University of Chicago, Chicago, IL
⁶University of Toronto, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
⁷Mount Sinai Medical Center, New York, NY
⁸Mayo Clinic, Rochester, MN
⁹Janssen Pharmaceutica NV, Beerse, Belgium
¹⁰Janssen-Cilag SpA, Cologno Monzese, Italy
¹¹Cilag GmbH International, Zug, Switzerland
¹²Janssen-Cilag GmbH, Neuss, Germany
¹³Janssen-Cilag N.V., High Wycombe, United Kingdom
¹⁴Janssen R&D, Raritan, NJ
¹⁵Legend Biotech USA, Piscataway, NJ
¹⁶Clinical Hematology, University Hospital Hotel-Dieu, Nantes, France
¹⁷Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany

Andrew J. Cowan, MD¹, Margot Pont, PhD^2*, Blythe Duke Sather, PhD³, Cameron J. Turtle, MBBS, PhD⁴, Brian G. Till, MD⁵, Edward Libby⁶, David G. Coffey, MD⁷, Sherilyn A. Tuazon, MD⁸, Brent L. Wood, MD, PhD⁹, Ted A Gooley, Ph.D.^5*, Qian Vicky Wu^5*, Mazyar Shadman, MD¹⁰, Jordan Gauthier, MD, MSc^5*, Aude G. Chapuis, MD¹, Filippo Milano, MD, PhD¹, David G. Maloney, MD, PhD¹, Stanley R. Riddell, MD^1* and Damian J. Green, MD¹

¹Fred Hutchinson Cancer Research Center, Seattle, WA
²Fred Hutchinson Cancer Research center, Seattle, WA
³Lyell Immunopharma, Seattle, WA
⁴Fred Hutchinson Cancer Research Ctr., Seattle, WA
⁵Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
⁶Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA
⁷Myeloma Program, Department of Medicine, University of Miami, Sylvester Comprehensive Cancer Center, Miami
⁸Clinical Research Division, Fred Hutch Cancer Research Center, Seattle, WA
⁹Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA
¹⁰University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA

Aina Oliver-Caldés^1*, Marta Español-Rego^1*, Aintzane Zabaleta, PhD^2*, Susana Inogés, MD, PhD^2*, Ascensión López-Diaz de Cerio, PhD^2*, Veronica Gonzalez-Calle, MD, PhD^3*, Valentin Cabañas, MD^4*, Beatriz Martin-Antonio, PhD^5*, Lorena Pérez-Amill^1*, Juan Luis Reguera^6*, Juan Roberto Rodriguez-Madoz, PhD^7*, Paula Rodríguez-Otero, MD, PhD^2*, Daniel Benítez-Ribas^1*, Mari-Pau Mena^1*, Marta Lasa^2*, Luis Gerardo Rodríguez-Lobato, MD, PhD^1*, Azucena González^1*, Laura Rosinol^8*, Jose Maria Moraleda, MD, PhD^4*, Felipe Prósper, MD, PhD^2*, Álvaro Urbano-Ispizua, MD, PhD^1*, Maria-Victoria Mateos³, Manel Juan, MD^1*, Bruno Paiva, PhD^2*, Mariona Pascal^1* and Carlos Fernandez de Larrea, MD, PhD¹

¹Hospital Clínic de Barcelona. IDIBAPS. University of Barcelona, Barcelona, Spain
²Clínica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), IDISNA, CIBERONC Pamplona, Pamplona, Spain
³Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), Salamanca, Spain
⁴Hospital Clínico Universitario Virgen de la Arrixaca. IMIB-Arrixaca. University of Murcia, Murcia, Spain
⁵Instituto de Investigación Sanitaria-Fundación Jimenez Diaz, Madrid, Spain
⁶Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC/CIBERONC), University of Sevilla, Sevilla, Spain
⁷Hemato-Oncology Program, CIMA Universidad de Navarra, Pamplona, Spain
⁸Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain